Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

BACKGROUND: Irritable bowel syndrome (IBS) is common, affecting 10–20% of the adult population worldwide, with many people reporting ongoing symptoms despite first-line therapies. Cognitive behavioural therapy (CBT) is recommended in guidelines for refractory IBS but there is insufficient access to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Gastroenterol Hepatol
Hlavní autoři: Everitt, Hazel A, Landau, Sabine, O'Reilly, Gilly, Sibelli, Alice, Hughes, Stephanie, Windgassen, Sula, Holland, Rachel, Little, Paul, McCrone, Paul, Bishop, Felicity L, Goldsmith, Kim, Coleman, Nicholas, Logan, Robert, Chalder, Trudie, Moss-Morris, Rona
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier B.V 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026694/
https://ncbi.nlm.nih.gov/pubmed/31492643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(19)30243-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky